• News
  • SAN DIEGO
  • Health

Neurocrine Biosciences granted two patents

Neurocrine Biosciences Inc. (Nasdaq: NBIX) has announced that two more patents have been granted related to the company's proprietary Vesicular Monoamine Transporter 2 inhibitor.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Neurocrine Biosciences Inc.

Company Website

12790 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
NBIX
31.70
  0.12  
+ 0.38%
454,564,000
32.67
12.17

Insider Trade Data

Date Insider Shares Type Value
01/16/2015 Bozigian, Haig P 1,625 Sell $50,034
01/16/2015 Coughlin, Timothy P 1,750 Sell $53,918
01/16/2015 Gano, Kyle 27,875 Sell $835,563
01/16/2015 Gorman, Kevin Charles 3,750 Sell $115,463
01/16/2015 Grigoriadis, Dimitri E 21,625 Sell $650,001

Neurocrine Biosciences Inc. Executive(s):

Kevin Gorman

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!